State Ledger
Company profile

Arcus Biosciences, Inc. CIK 1724521

Ticker
RCUS (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Hayward, CA 94545
Fiscal year end
2025 (FY)
Market Data
Close
$24.33
Change
-$0.08
Change %
-0.33%
Volume
100,193

RCUS · trading date Oct 12, 2026 · previous close $24.41 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$247.00M
Net income
-$353.00M
Total assets
$1.14B
Total liabilities
—
Stockholders' equity
$631.00M
Cash & equivalents
$222.00M
Operating income
-$386.00M
Operating cash flow
-$482.00M
Capital expenditures
$2.00M

Fiscal year 2025, via 10-K filed 2026-02-25. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-156.3%
Net margin
-142.9%
Free cash flow
-$484.00M
Free cash flow margin
-196.0%
Liabilities / assets
—
Equity / assets
55.4%
CapEx / revenue
0.8%
Operating cash flow / net income
1.37×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $247.00M -$353.00M $1.14B — $631.00M
2024 $258.00M -$283.00M $1.15B — $485.00M
2023 $117.00M -$307.00M $1.10B — $462.00M
2022 $112.00M -$267.00M $1.35B — $657.00M
2021 $383.00M $53.00M $1.59B $750.45M $842.00M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-08-24
Financials filed via
Form 10-K
filed 2026-02-25

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Hayward, CA 94545
3928 POINT EDEN WAY
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:18 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies